Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial
- PMID: 28644321
- DOI: 10.1097/AOG.0000000000002125
Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial
Comment in
-
In Reply.Obstet Gynecol. 2017 Jul;130(1):219-220. doi: 10.1097/AOG.0000000000002126. Obstet Gynecol. 2017. PMID: 28644322 No abstract available.
Comment on
-
Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial.Obstet Gynecol. 2017 Apr;129(4):615-620. doi: 10.1097/AOG.0000000000001928. Obstet Gynecol. 2017. Retraction in: Obstet Gynecol. 2020 Apr;135(4):980. doi: 10.1097/AOG.0000000000003836. PMID: 28277352 Retracted. Clinical Trial.
References
-
- Maher MA, Sayyed TM, Elkhouly N. Sildenafil citrate therapy for oligohydramnios: a randomized controlled trial. Obstet Gynecol 2017;129:615–20.
-
- Klein HH, Pich S. Cardiovascular changes during pregnancy. Herz 2003;28:173–4.
-
- Greenway CV, Lautt WW. Blood volume, the venous system, preload, and cardiac output. Can J Physiol Pharmacol 1986;64:383–7.
-
- Vos JJ, Scheeren TW, Loer SA, Hoeft A, Wietasch JK. Do intravascular hypo- and hypervolaemia result in changes in central blood volumes? Br J Anaesth 2016;116:46–53.
-
- Romero TE, Friedman WF. Limited left ventricular response to volume overload in the neonatal period: a comparative study with the adult animal. Pediatr Res 1979;13:910–5.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
